Clinical trial

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

NCT04503265

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention AMXI-5001:Dose Escalation Phase I Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention AMXI-5001:Dose Expansion Phase II Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-08-12

PhasePHASE1 / PHASE2

Conditions

Advanced Malignant Neoplasmunresolved

Breast Cancerverified · MONDO: breast cancer

Ovarian Cancerverified · MONDO: ovarian cancer

Homologous Recombination Deficiencyunresolved

Prostate Cancerverified · MONDO: prostate cancer

Pancreatic Cancerverified · MONDO: malignant pancreatic neoplasm

Interventions

AMXI-5001:Dose Escalation Phase IDRUG

AMXI-5001:Dose Expansion Phase IIDRUG

Sponsors & collaborators

AtlasMedx, Incorporatedlead sponsor

Mapped research locations

HoustonTexas, United States1 Los AngelesCalifornia, United States1 BaltimoreMaryland, United States1 NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04503265 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.